Corline Biomedical AB Cash Flow-to-Debt Ratio
Corline Biomedical AB cash flow-to-debt ratio. Corline Biomedical AB (CLBIO) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2026, meaning its operating cash flow of Skr122.00K could theoretically repay 0% of its total liabilities (Skr15.18 Million) in one year. Check CLBIO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Corline Biomedical AB (2013–2025)
Cash flow-to-debt ratio of Corline Biomedical AB from 2013 to 2025. Historical debt coverage capacity for Corline Biomedical AB across 13 annual periods. Check how high is Corline Biomedical AB's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Corline Biomedical AB Cash Flow-to-Debt Ratio by Year (2013–2025)
Corline Biomedical AB cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Corline Biomedical AB. For the full cash flow conversion analysis, see Corline Biomedical AB (CLBIO) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.67x | Skr-17.69 Million | Skr4.82 Million | ▼ -233.5% |
| 2024 | -1.10x | Skr-8.64 Million | Skr7.85 Million | ▼ -943.5% |
| 2023 | 0.13x | Skr886.00K | Skr6.79 Million | ▲ +114.6% |
| 2022 | -0.90x | Skr-6.45 Million | Skr7.19 Million | ▼ -74.9% |
| 2021 | -0.51x | Skr-4.83 Million | Skr9.43 Million | ▲ +36.7% |
| 2020 | -0.81x | Skr-5.07 Million | Skr6.25 Million | ▲ +74.0% |
| 2019 | -3.12x | Skr-13.84 Million | Skr4.43 Million | ▼ -505.0% |
| 2018 | -0.52x | Skr-4.10 Million | Skr7.95 Million | ▲ +43.0% |
| 2017 | -0.90x | Skr-4.98 Million | Skr5.50 Million | ▲ +68.3% |
| 2016 | -2.85x | Skr-7.21 Million | Skr2.53 Million | ▼ -152.3% |
| 2015 | -1.13x | Skr-4.23 Million | Skr3.74 Million | ▼ -450.0% |
| 2014 | -0.21x | Skr-2.32 Million | Skr11.29 Million | ▲ +57.1% |
| 2013 | -0.48x | Skr-2.76 Million | Skr5.76 Million | — |